KEY POINTS

FDA recommendations will favor COVID-19 vaccination for those 65 and older or with certain risk of severe symptoms.

Consideration of vaccination licensing for healthy persons aged 6 months to 64 years needs trial data.

The vaccines will likely be available to 100-200 million Americans.

The U.S. Food and Drug Administration plans to change its recommendations for getting a COVID-19 vaccination, suggesting the vaccine for those 65 and older and for those older than 6 months of age who have health conditions that make severe COVID-19 symptoms a risk.

Those who don’t fit one of the categories likely will not have access.

“For all healthy persons — those with no risk factors for severe COVID-19 — between the ages of 6 months and 64 years, the FDA anticipates the need for random

See Full Page